Subclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF. Our objective was to evaluate clinical and echocardiographic variables to identify patients who develop HFpEF.Methods and Results Clinical, laboratory, and echocardiographic data were retrospectively collected for 81 patients without HF and 81 matched patients with HFpEF at the time of first documentation of subclinical diastolic dysfunction. Unsupervised clustering identified 3 subgroups which differed in gender composition, severity of cardiac hypertrophy and aortic stenosis, NT-proBNP, percentage of patients who progressed to HFpEF, and timing of disease progression from diastolic dysfunction to HFpEF to death. Clusters that had higher percentages of women had progressively milder cardiac hypertrophy, less severe aortic stenosis, lower NT-proBNP, were diagnosed at an older age with HFpEF, and survived to an older age. Independent predictors of HFpEF for the entire cohort included diabetes, chronic kidney disease, atrial fibrillation, and diuretic use, with additional predictive variables found for each cluster.Conclusions Cluster analysis can identify phenotypically distinct subgroups of patients with diastolic dysfunction. Clusters differ in HFpEF and mortality outcome. In addition, the variables that correlate with and predict HFpEF outcome differ among clusters.

Figure 1

Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
On 26 Apr, 2020
Received 25 Apr, 2020
On 15 Apr, 2020
Invitations sent on 07 Apr, 2020
On 03 Mar, 2020
On 02 Mar, 2020
On 02 Mar, 2020
Posted 13 Nov, 2019
On 08 Feb, 2020
Received 28 Jan, 2020
Received 02 Dec, 2019
On 21 Nov, 2019
On 21 Nov, 2019
Invitations sent on 21 Nov, 2019
On 21 Nov, 2019
On 12 Nov, 2019
On 11 Nov, 2019
On 04 Nov, 2019
On 26 Apr, 2020
Received 25 Apr, 2020
On 15 Apr, 2020
Invitations sent on 07 Apr, 2020
On 03 Mar, 2020
On 02 Mar, 2020
On 02 Mar, 2020
Posted 13 Nov, 2019
On 08 Feb, 2020
Received 28 Jan, 2020
Received 02 Dec, 2019
On 21 Nov, 2019
On 21 Nov, 2019
Invitations sent on 21 Nov, 2019
On 21 Nov, 2019
On 12 Nov, 2019
On 11 Nov, 2019
On 04 Nov, 2019
Subclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF. Our objective was to evaluate clinical and echocardiographic variables to identify patients who develop HFpEF.Methods and Results Clinical, laboratory, and echocardiographic data were retrospectively collected for 81 patients without HF and 81 matched patients with HFpEF at the time of first documentation of subclinical diastolic dysfunction. Unsupervised clustering identified 3 subgroups which differed in gender composition, severity of cardiac hypertrophy and aortic stenosis, NT-proBNP, percentage of patients who progressed to HFpEF, and timing of disease progression from diastolic dysfunction to HFpEF to death. Clusters that had higher percentages of women had progressively milder cardiac hypertrophy, less severe aortic stenosis, lower NT-proBNP, were diagnosed at an older age with HFpEF, and survived to an older age. Independent predictors of HFpEF for the entire cohort included diabetes, chronic kidney disease, atrial fibrillation, and diuretic use, with additional predictive variables found for each cluster.Conclusions Cluster analysis can identify phenotypically distinct subgroups of patients with diastolic dysfunction. Clusters differ in HFpEF and mortality outcome. In addition, the variables that correlate with and predict HFpEF outcome differ among clusters.

Figure 1

Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Loading...